About This Practice Area

Chemistry, Manufacturing, and Controls (CMC) is the technical backbone that determines the commercial and clinical viability of a therapeutic asset. At Livasyst, we recognize that CMC is more than a regulatory requirement, it is the definitive "story" of the product identity. As articulated by industry thought leaders, success in this domain requires a mastery of functional interdependencies.

We specialize in identifying the technical stewards - typically from the level of Principal Scientist to Head of CMC - who can synchronize the reciprocal relationship between Active Pharmaceutical Ingredient (API) synthesis, process development, and patient-centric formulation. In an era where CMC deficiencies account for nearly 20% of non-approval decisions, Livasyst identifies the talent capable of managing the "dimensionality explosion" encountered during scale-up, ensuring that the Phase III product administered to patients is identical to the one that eventually reaches the market.

Technical Stewardship

Strategic oversight for 100+ specialized CMC and Technical Operations roles.

Scientific Benchmarking

Vetting leaders who combine experimental depth with translational awareness.

Blueprint Success

99%+ placement rate for hard-to-fill MSAT and Regulatory CMC positions.

Key Roles We Source

Strategic Leadership across Technical Operations & Formulation

Principal Formulation Scientists

Visionaries who optimize the interaction between API and excipients, ensuring bioavailability and stability in complex delivery systems like LNPs or autoinjectors.

Heads of MSAT (Manufacturing Science & Technology)

The essential "bridge" leaders responsible for technology transfer, process validation, and ensuring manufacturing methods produce identical results across multiple global sites.

Regulatory CMC Strategists

Specialists who translate complex technical data into a clear narrative for health authorities, authoring Module 3 CTD sections that accelerate the path to approval.

CDMO Stewardship Leads

Executives who provide technical oversight of external manufacturing partners, mitigating risk and ensuring supply chain resilience for both clinical and commercial materials.

Principal Analytical Scientists

Leaders who define the Critical Quality Attributes (CQAs) and validated methods required to establish a roadmap for product Safety, Identity, Strength, Purity, and Quality (SISPQ).

Heads of Technical Operations / VPs of CMC

Strategic architects who define the long-term CMC roadmap, manage multi-million dollar budgets, and drive cross-functional alignment with Discovery and Clinical teams.

Our Recruitment Process

A Methodology Informed by Scientific and Regulatory Rigor

1. Strategic Milestone Mapping

We align your leadership search with specific pipeline milestones, from IND-enabling data packages to Phase II/III CMC briefing books.

2. Scientific Peer-Review

Our consultants possess the technical depth to vet candidates on their patent history, structural characterization skills, and record of successful NDA/MAA filings.

3. Cross-Functional Assessment

Evaluating a leader’s "systems thinking" and their ability to manage the ripple effects that process changes in the lab have on global regulatory and commercial strategy.

4. CDMO Capability Vetting

We prioritize leaders with proven records in external manufacturing management, evaluating their history of CDMO selection and performance management.

5. Quality Culture Integration

Assessing a candidate's ability to champion "Quality as Responsibility," ensuring that compliance is embedded into the organizational culture, not just the oversight function.

6. Seamless Transition Support

Facilitating the onboarding of high-caliber "Scientist-Leaders" to ensure they are mission-ready to protect your asset’s license to operate.

Why Choose LIVASYST for CMC Talent

Our Unique Advantages in CMC Recruitment

The "Blueprint vs. Proof" Philosophy

We vet candidates who understand that CMC defines the "Good" product (The Blueprint) while GMP provides the daily evidence of its execution (The Proof).

Advanced Modality Expertise

Livasyst excels in identifying scarce talent for next-generation modalities, including cell/gene therapy, mRNA platforms, and viscous product formulations.

Regulatory Resilience

We provide access to leaders who are fluent in the latest FDA, EMA, and ICH guidelines, proactively mitigating the risk of non-approval decisions.

Market Mapping

Discreetly mapping the talent landscape to identify passive candidates with proven records in developing therapies and navigating regulatory pathways.

Ready to Secure Your Product Blueprint?

Let’s discuss your pipeline’s technical leadership needs and how we can identify the talent that will turn your molecular potential into a scalable reality.

Start Your Search